Human Rights, Inclusiveness – Key Themes At UN Multi-Stakeholder Meeting On UHC 30/04/2019 David Branigan New York – Strengthening references to sexual and reproductive health and rights, marginalised people, and public-private partnerships that ensure rights and inclusion, were among the core proposals pitched yesterday at a United Nations multi-stakeholder meeting on Universal Health Coverage (UHC), involving representatives of government, UN agencies, civil society and the private sector. The milestone meeting […] Continue reading -> Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Generics Industry Questions WIPO-Pharma Medicines Patent Database 18/04/2019 William New An international group representing the largest producers of generic medicines worldwide has raised concerns about the effect of a medicines patent database developed jointly by the World Intellectual Property Organization and the innovative pharmaceutical industry. But big pharma tells Health Policy Watch it is working to settle the concerns. Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Health Savings Of Reduced Air Pollution “Dwarf” Cleanup Costs, Says UN Report 13/03/2019 David Branigan UN Environment today released its sixth Global Environment Outlook (GEO-6), assessing the state of the environment over the last five years. The report highlights studies published in the scientific press last year estimating that the health benefits of reducing air pollution would be 1.4 to 2.5 times greater than the costs of mitigation. Savings between […] Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Drug Price Transparency: 10 Countries Back World Health Assembly Resolution 30/04/2019 Elaine Ruth Fletcher Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva. Image […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Generics Industry Questions WIPO-Pharma Medicines Patent Database 18/04/2019 William New An international group representing the largest producers of generic medicines worldwide has raised concerns about the effect of a medicines patent database developed jointly by the World Intellectual Property Organization and the innovative pharmaceutical industry. But big pharma tells Health Policy Watch it is working to settle the concerns. Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Health Savings Of Reduced Air Pollution “Dwarf” Cleanup Costs, Says UN Report 13/03/2019 David Branigan UN Environment today released its sixth Global Environment Outlook (GEO-6), assessing the state of the environment over the last five years. The report highlights studies published in the scientific press last year estimating that the health benefits of reducing air pollution would be 1.4 to 2.5 times greater than the costs of mitigation. Savings between […] Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Generics Industry Questions WIPO-Pharma Medicines Patent Database 18/04/2019 William New An international group representing the largest producers of generic medicines worldwide has raised concerns about the effect of a medicines patent database developed jointly by the World Intellectual Property Organization and the innovative pharmaceutical industry. But big pharma tells Health Policy Watch it is working to settle the concerns. Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Health Savings Of Reduced Air Pollution “Dwarf” Cleanup Costs, Says UN Report 13/03/2019 David Branigan UN Environment today released its sixth Global Environment Outlook (GEO-6), assessing the state of the environment over the last five years. The report highlights studies published in the scientific press last year estimating that the health benefits of reducing air pollution would be 1.4 to 2.5 times greater than the costs of mitigation. Savings between […] Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Generics Industry Questions WIPO-Pharma Medicines Patent Database 18/04/2019 William New An international group representing the largest producers of generic medicines worldwide has raised concerns about the effect of a medicines patent database developed jointly by the World Intellectual Property Organization and the innovative pharmaceutical industry. But big pharma tells Health Policy Watch it is working to settle the concerns. Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Health Savings Of Reduced Air Pollution “Dwarf” Cleanup Costs, Says UN Report 13/03/2019 David Branigan UN Environment today released its sixth Global Environment Outlook (GEO-6), assessing the state of the environment over the last five years. The report highlights studies published in the scientific press last year estimating that the health benefits of reducing air pollution would be 1.4 to 2.5 times greater than the costs of mitigation. Savings between […] Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
“Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Health Savings Of Reduced Air Pollution “Dwarf” Cleanup Costs, Says UN Report 13/03/2019 David Branigan UN Environment today released its sixth Global Environment Outlook (GEO-6), assessing the state of the environment over the last five years. The report highlights studies published in the scientific press last year estimating that the health benefits of reducing air pollution would be 1.4 to 2.5 times greater than the costs of mitigation. Savings between […] Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Health Savings Of Reduced Air Pollution “Dwarf” Cleanup Costs, Says UN Report 13/03/2019 David Branigan UN Environment today released its sixth Global Environment Outlook (GEO-6), assessing the state of the environment over the last five years. The report highlights studies published in the scientific press last year estimating that the health benefits of reducing air pollution would be 1.4 to 2.5 times greater than the costs of mitigation. Savings between […] Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Health Savings Of Reduced Air Pollution “Dwarf” Cleanup Costs, Says UN Report 13/03/2019 David Branigan UN Environment today released its sixth Global Environment Outlook (GEO-6), assessing the state of the environment over the last five years. The report highlights studies published in the scientific press last year estimating that the health benefits of reducing air pollution would be 1.4 to 2.5 times greater than the costs of mitigation. Savings between […] Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 Catherine Saez The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May. Continue reading -> Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Digital Health Technologies Can Unlock Huge Potential From Research Bench To Outpatient Care, Speakers Tell OECD 14/12/2018 Editorial team There is a yawning gap between the potential of digital technologies to transform health care, and the everyday constraints on efficient data use at health clinics and hospitals to improve patient treatment. Continue reading -> Posts navigation Older postsNewer posts